Although initial studies demonstrated HMGB1 was a late mediator of sepsis, recent findings indicate HMGB1 plays an important role in models of non-infectious inflammation, such as autoimmunity, cancer, trauma, and ischemia reperfusion injury. This evidence concerns the gene HMGB1 and cancer.